Fever, a common clinical symptom, often serves as a crucial sign of underlying pathologies. Its effective management is paramount in ensuring patient comfort and mitigating potential complications. This article provides a comprehensive guide to managing fever in clinical practice.
Fever is a complex physiological response to infection or inflammation, characterized by an elevation in body temperature above the normal range. It's a protective mechanism that enhances the immune response. However, persistent or high-grade fever may lead to deleterious effects, necessitating intervention.
Accurate evaluation forms the cornerstone of fever management. A thorough history and physical examination often provide valuable clues to the underlying etiology. Investigations should be guided by the clinical suspicion and may include complete blood count, cultures, imaging, or specific serological tests.
Management of fever primarily involves treating the underlying cause. Antipyretics, such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), can be used for symptomatic relief. However, their use should be judicious, considering potential side effects. Physical methods of cooling, such as tepid sponging, may be employed in high-grade fever.
In immunocompromised patients, fever may be the only sign of serious infection. Prompt evaluation and empirical antibiotics may be warranted. In critically ill patients, fever could exacerbate underlying conditions, necessitating aggressive management. Pediatric and geriatric populations may require tailored approaches, considering their unique physiology and pharmacokinetics.
Managing fever in clinical practice involves a nuanced understanding of its pathophysiology, accurate evaluation, and individualized management strategies. Clinicians must balance the benefits of fever as a protective response against the risks of potential complications. Ongoing research and clinical experience continue to inform and refine our approach to this common yet complex clinical symptom.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation